Actively Recruiting
Prospective Clinical Study of Minimally Invasive Hemodynamic Monitoring Outcomes in Cardiac Ablation Procedures
Led by Istanbul University - Cerrahpasa · Updated on 2026-05-22
27
Participants Needed
1
Research Sites
4 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are evaluating the use of Pressure Recording Analytical Method (PRAM)-based minimally invasive hemodynamic monitoring during cardiac ablation procedures. This observational study focuses on adults undergoing cardiac catheter ablation, aiming to assess how this monitoring method can support management during these complex procedures, which carry risks due to arrhythmia and potential complications. The study is conducted at Istanbul University-Cerrahpa5fa Cardiology Institute and follows ethical guidelines including informed consent. Participants will receive standard monitoring such as electrocardiography, heart rate, pulse oximetry, and invasive arterial blood pressure via radial or femoral access. Alongside, continuous beat-to-beat hemodynamic data will be collected using the MostCare ae system applying the PRAM algorithm. Data collection happens at three key times: before, during, and after the ablation procedure. The study focuses on various heart function parameters including cardiac output, stroke volume, and vascular resistance. During the study, participants will have continuous monitoring and multiple hemodynamic measurements taken at set intervals around the ablation. Researchers will analyze changes over time in these parameters to evaluate PRAM's role in guiding clinical decisions during the procedure. The study will also assess patient safety and generate evidence to inform future guidelines for anesthesia management in these settings. Total participation includes the ablation procedure and associated monitoring time.
CONDITIONS
Brief Title
Minimally Invasive Hemodynamic Monitoring in Cardiac Ablation
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 65 18 years
- Scheduled for cardiac catheter ablation in the electrophysiology laboratory
- Indication for ablation confirmed by a cardiologist
- Ability to provide written informed consent
- Planned invasive arterial blood pressure monitoring during the procedure
You will not qualify if you...
- Refusal or inability to provide informed consent
- Failure to identify arrhythmogenic focus leading to cancellation of ablation procedure
- Severe hemodynamic instability prior to procedure
- Contraindication to invasive arterial catheterization
- Incomplete hemodynamic data acquisition
- Pregnancy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Day of the ablation procedure
Participants undergo cardiac catheter ablation procedures with standard and minimally invasive hemodynamic monitoring.
1 procedure visit including monitoring before, during, and after ablation
Duration - Up to 1 day post-procedure
Participants' hemodynamic data are observed and analyzed to evaluate intra-procedural changes and clinical utility of monitoring.
Data collected at three time points: before, during, and after ablation
Trial Site Locations
Total: 1 location
1
Istanbul University-Cerrahpasa, Institute of Cardiology
Istanbul, Turkey (Türkiye)
Actively Recruiting
Research Team
G
GOZDE ALTUN
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here